One in eight middle-aged UK adults is at risk of developing cirrhosis of the liver, liver failure and death because they have a potentially serious form of liver disease. The primary cause of this disease? Being overweight, according to new research. Scans of almost 3,000 people from the UK Biobank research project showed that 12% had inflamed, fatty livers. What’s particularly alarming is the silent nature of this disease epidemic, with symptoms often not presenting themselves until permanent damage has been done. However, the condition is reversible if caught in time. The good news is that a new type of MRI scan is showing lots of promise, offering a non-invasive way to evaluate the nature and severity of liver disease. Developed by Perspectum Diagnositics, a spin-off company from the University of Oxford, the new scan utilises smart health technology called LiverMultiScan. Dr Rajarshi Banerjee, CEO of Perspectum Diagnostics said: "LiverMultiScan is a great example of a smart health technology discovered and developed by UK clinicians and scientists with clear benefits for patients, the NHS, and taxpayers. Until now, needle biopsies have been the gold standard for assessing liver disease, but they are costly, invasive, painful and carry some health risks. Meanwhile, LiverMultiScan can be used in any MRI scanner, but it is not part of routine practice yet. David Breen, associate professor of radiology at University Hospital Southampton, said: "The scan gives a map of the entire liver as opposed to a needle-core biopsy which samples just one area and can be unpleasant. "It also allows us to re-scan patients over time and see if they improve."